PEARQ — Pear Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Pear Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	104	124	175	59.3
Net Total Accounts Receivable
Net Total Receivables	1.01	0.257	1.79	6.94
Prepaid Expenses
Total Other Current Assets
Total Current Assets	107	126	185	73
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.68	4.28	6.25	15
Other Long Term Assets
Total Assets	110	132	197	95.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17.1	40.7	47.2	49.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	30.9	45.3	107	64.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	78.8	87.1	90.4	30.6
Total Liabilities & Shareholders' Equity	110	132	197	95.1
Total Common Shares Outstanding